Anavex Life Sciences Corp. (NASDAQ: AVXL)
| Pre-Market |
Intra-Day |
After-Hours |
| 2.83 (0.01 / 0.35%) |
2.57 (-0.25 / -8.87%) |
2.63 (0.06 / 2.33%) |
| 05-Jun 09:04 |
05-Jun 16:00 |
05-Jun 18:59 |
Sector:
Healthcare || Industry:
Biotechnology
| Previous Close |
2.82 |
Year Low |
2.57 |
| Open |
2.79 |
Year High |
13.99 |
| Day Low |
2.57 |
Price Avg 50 |
3.11 |
| Day High |
2.81 |
Price Avg 200 |
5.39 |
| Volume |
915.66 K |
Market Cap |
238.17 M |
News
Analysis
| AVXL |
-8.87 |
-12.88 |
-23.51 |
-46.01 |
-41.59 |
-66.97 |
Earnings
| 02/09/2026 |
BMO |
AVXL |
Anavex Life Sciences |
Q1 2026 |
EPS |
-0.11 |
-0.06 |
45.45 |
-0.14 |
57.10 |
|
| 02/09/2026 |
BMO |
AVXL |
Anavex Life Sciences |
Q1 2026 |
REV |
|
|
0.00 |
|
0.00 |
|
| 11/25/2025 |
BMO |
AVXL |
Anavex Life Sciences |
Q4 2025 |
EPS |
-0.15 |
-0.11 |
26.67 |
-0.14 |
21.40 |
|
| 11/25/2025 |
BMO |
AVXL |
Anavex Life Sciences |
Q4 2025 |
REV |
|
|
|
|
|
|
| 08/12/2025 |
BMO |
AVXL |
Anavex Life Sciences |
Q3 2025 |
EPS |
-0.14 |
-0.16 |
-14.29 |
-0.14 |
-14.30 |
|
| 08/12/2025 |
BMO |
AVXL |
Anavex Life Sciences |
Q3 2025 |
REV |
|
|
0.00 |
|
0.00 |
|
Outlooks
* Growth at Outlook Mid-point against Estimate
Ratings
| 03/31/2026 |
AVXL |
D. Boral Capital |
Buy |
Buy |
Maintain |
| 03/26/2026 |
AVXL |
D. Boral Capital |
Buy |
Buy |
Maintain |
| 03/23/2026 |
AVXL |
D. Boral Capital |
Buy |
Buy |
Maintain |
| 02/10/2026 |
AVXL |
HC Wainwright & Co. |
Buy |
Buy |
Maintain |
| 02/09/2026 |
AVXL |
D. Boral Capital |
Buy |
Buy |
Maintain |
| 01/06/2026 |
AVXL |
D. Boral Capital |
Buy |
Buy |
Maintain |
Dividends
Sign-Up to see the full list of CATALYSTS in the Calendars